|
Cvs Health Corporation (NYSE: CVS) |
|
|
|
| |
Cvs Health Corporation's vs. its Suppliers Results
(List of Suppliers, Financial Results 12 Months from the last period ending MRQ, in Millions of $)
|
Select the Relationship:
|
|
Select the Category:
|
|
| COMPANY NAME |
TICKER |
REVENUE |
NET INCOME |
NET MARGIN |
CASH FLOW |
| Cvs Health Corporation |
1 Q 2025 |
CVS |
378,960.00 |
5,244.00 |
1.38 % |
239.00 |
| Mckesson Corporation |
1 Q 2025 |
MCK |
359,051.00 |
3,481.00 |
0.97 % |
1,371.00 |
| Cardinal Health Inc |
1 Q 2025 |
CAH |
222,127.00 |
1,560.00 |
0.7 % |
-425.00 |
| Elevance Health Inc |
1 Q 2025 |
ELV |
183,325.00 |
5,906.00 |
3.22 % |
1,340.00 |
| Johnson and Johnson |
1 Q 2025 |
JNJ |
89,331.00 |
21,810.00 |
24.41 % |
13,001.00 |
| Merck and Co Inc |
1 Q 2025 |
MRK |
63,922.00 |
17,451.00 |
27.3 % |
3,061.00 |
| Pfizer Inc |
1 Q 2025 |
PFE |
62,463.00 |
7,912.00 |
12.67 % |
702.00 |
| Abbvie Inc |
1 Q 2025 |
ABBV |
57,367.00 |
4,203.00 |
7.33 % |
-12,892.00 |
| Eli Lilly And Company |
1 Q 2025 |
LLY |
49,003.20 |
11,106.40 |
22.66 % |
633.10 |
| Bristol myers Squibb Company |
1 Q 2025 |
BMY |
47,636.00 |
5,437.00 |
11.41 % |
1,541.00 |
| Thermo Fisher Scientific Inc |
1 Q 2025 |
TMO |
42,898.00 |
6,518.00 |
15.19 % |
-1,347.00 |
| Abbott Laboratories |
1 Q 2025 |
ABT |
42,344.00 |
13,502.00 |
31.89 % |
248.00 |
| Amgen Inc |
4 Q 2024 |
AMGN |
33,424.00 |
4,090.00 |
12.24 % |
1,029.00 |
| Medtronic Plc |
4 Q 2025 |
MDT |
33,199.00 |
4,290.00 |
12.92 % |
-383.00 |
| Gilead Sciences Inc |
1 Q 2025 |
GILD |
28,735.00 |
5,965.00 |
20.76 % |
3,208.00 |
| Becton Dickinson And Company |
1 Q 2025 |
BDX |
20,867.00 |
1,498.00 |
7.18 % |
-1,647.00 |
| Boston Scientific Corporation |
1 Q 2025 |
BSX |
17,553.00 |
2,025.00 |
11.54 % |
-1,577.00 |
| Labcorp Holdings Inc |
1 Q 2025 |
LH |
13,177.40 |
731.80 |
5.55 % |
270.10 |
| International Flavors and Fragrances Inc |
1 Q 2025 |
IFF |
11,428.00 |
-831.00 |
-7.27 % |
-121.00 |
| Quest Diagnostics Inc |
1 Q 2025 |
DGX |
10,158.00 |
948.00 |
9.33 % |
-286.00 |
| Baxter International Inc |
1 Q 2025 |
BAX |
9,669.00 |
-551.00 |
-5.7 % |
-734.00 |
| Biogen Inc |
1 Q 2025 |
BIIB |
9,816.40 |
1,479.30 |
15.07 % |
1,534.20 |
| Edwards Lifesciences Corporation |
1 Q 2025 |
EW |
5,253.50 |
4,175.10 |
79.47 % |
1,919.80 |
| Hawkins Inc |
1 Q 2025 |
HWKN |
974.43 |
84.35 |
8.66 % |
-2.05 |
| Neogenomics Inc |
1 Q 2025 |
NEO |
671.88 |
-77.59 |
-11.55 % |
14.28 |
| Owlet Inc |
1 Q 2025 |
OWLT |
83.09 |
-18.08 |
-21.76 % |
-1.79 |
| Northern Technologies International Corporation |
1 Q 2025 |
NTIC |
84.45 |
4.76 |
5.64 % |
0.26 |
| Western New England Bancorp Inc |
1 Q 2025 |
WNEB |
72.97 |
11.01 |
15.09 % |
87.97 |
| Agile Therapeutics Inc |
2 Q 2024 |
AGRX |
19.72 |
-15.85 |
-80.39 % |
0.06 |
| United guardian Inc |
1 Q 2025 |
UG |
11.41 |
2.89 |
25.3 % |
-5.80 |
| Nano Magic Inc |
3 Q 2024 |
NMGX |
2.14 |
-3.83 |
-179.37 % |
-0.08 |
| Know Labs Inc |
1 Q 2025 |
KNW |
0.00 |
0.00 |
- |
0.00 |
| APROX. MARKET |
1 Q |
SUBTOTAL |
1,414,667.57 |
122,694.25 |
8.67 % |
10,539.04 |
|
